Catalyst

Slingshot members are tracking this event:

Lilly (LLY) Receives Inquiries Over Certain Aspects of Drug Pricing (Date is an estimate for "September")

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VRX

100%
LLY

100%
MRK

100%

Additional Information

Management Comment In September 2015, we were advised that the U.S. Attorney’s office for the Eastern District of Pennsylvania and the Civil Division of the U.S. Department of Justice are conducting an inquiry concerning our treatment of certain distribution service agreements with wholesalers when calculating and reporting Average Manufacturer Prices in connection with the Medicaid drug rebate program. We are voluntarily responding to this request.
https://www.sec.gov/...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Drug Pricing